T. Kohmoto et al., PHYSIOLOGY, HISTOLOGY, AND 2-WEEK MORPHOLOGY OF ACUTE TRANSMYOCARDIALCHANNELS MADE WITH A CO2-LASER, The Annals of thoracic surgery, 63(5), 1997, pp. 1275-1283
Background. Transmyocardial revascularization with a CO2 laser appears
to improve symptoms in patients with refractory angina. However, it r
emains controversial as to whether blood flow through the channels is
the mechanism of benefit, especially in the acute setting. Methods and
Results. Three protocols were used to test whether blood flows throug
h transmyocardial CO2 laser revascularization channels. First, channel
s were made in excised, cross-perfused dog hearts (n = 5) using a CO2
laser (The Heart Laser; PLC Systems Inc, Milford, MA; 40 J/pulse) foll
owed by ligation of the proximal left anterior descending coronary art
ery. Colored microspheres injected into the left ventricular chamber f
ailed to detect any significant transmyocardial blood flow. In the sec
ond protocol (n = 4), laser channels were created in the left anterior
descending artery territory, the left anterior descending artery was
ligated, and the hearts were excised after 24 hours. Triphenyltetrazol
ium chloride staining revealed that no viable myocardium was detected
around the laser channels in the ischemic myocardium. Finally, channel
s examined 2 weeks after creation in normal (n = 6) or ischemic (n = 4
) myocardium did not maintain their original caliber but were invaded
by granulation tissue, which included a large amount of smaller vascul
ar spaces and vessels of various sizes. Conclusions. Transmyocardial l
aser revascularization channels made with this CO2 laser did not provi
de acute myocardial perfusion or preserve myocardial viability in the
face of acute ischemia. Channel morphology changes dramatically within
the first 2 weeks. To the degree that these findings pertain to human
myocardium, the results suggest that transmyocardial blood flow may n
ot be the mechanism of benefit of this procedure, particularly in the
acute setting. (C) 1997 by The Society of Thoracic Surgeons.